Fetal Anomalies Associated with Novel Pathogenic Variants in TMEM94.Al-Hamed M.H., Alsahan N., Tulbah M., Kurdi W., Ali W., Sayer J.A., Imtiaz F.View abstractAnnotationFetal Anomalies Associated with Novel Pathogenic Variants in TMEM94.CategoriesSequences, Disease & VariantsSourceGeneRif: 9772PubMedEurope PMCGenes (Basel) 11:E967-E967 (2020)Mapped to5
Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.So J., Pasculescu A., Dai A.Y., Williton K., James A., Nguyen V., Creixell P., Schoof E.M., Sinclair J.[...], Colwill K.View abstractCategoriesInteractionSourceIntAct: Q12767PubMedEurope PMCSci Signal 8:rs3-rs3 (2015)Mapped to99+
The protein interaction landscape of the human CMGC kinase group.Varjosalo M., Keskitalo S., Van Drogen A., Nurkkala H., Vichalkovski A., Aebersold R., Gstaiger M.View abstractCategoriesInteractionSourceIntAct: Q12767PubMedEurope PMCCell Rep 3:1306-1320 (2013)Mapped to99+
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.Varjosalo M., Sacco R., Stukalov A., van Drogen A., Planyavsky M., Hauri S., Aebersold R., Bennett K.L., Colinge J.[...], Superti-Furga G.View abstractCategoriesInteractionSourceIntAct: Q12767PubMedEurope PMCNat Methods 10:307-314 (2013)Mapped to99+
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R.View abstractAnnotationClinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)CategoriesFunctionSourceGeneRif: 9772PubMedEurope PMCMol Med 16:247-253 (2010)Mapped to99+
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.Bantscheff M., Eberhard D., Abraham Y., Bastuck S., Boesche M., Hobson S., Mathieson T., Perrin J., Raida M.[...], Drewes G.View abstractCategoriesInteractionSourceIntAct: Q12767PubMedEurope PMCNat Biotechnol 25:1035-1044 (2007)Mapped to99+